Insider · CIK 0002039533
Todd Anderman
Files at OCUL (OCULAR THERAPEUTIX, INC). First filing Oct 10, 2025, latest Oct 10, 2025.
In brief
Todd Anderman files SEC Form 4 as officer at OCUL (OCULAR THERAPEUTIX, INC). Since Oct 10, 2025, Todd Anderman has reported 0 open-market buys worth $0 and 1 open-market sell worth $137k, the latest filed on Oct 10, 2025.
A track record needs three past buys with six months of prices behind them; Todd Anderman has 0, so none is measured yet.
The newest scored trade: sold $137k of OCUL on Oct 8, 2025, filed Oct 10, 2025, scored 26 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OCUL: OCULAR THERAPEUTIX, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | OCULAR THERAPEUTIX, INC | $137k 11,132 shares | -11% | +101% from low-12% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 8, 2026 | OCUL OCULAR THERAPEUTIX, INC. | 11,984 0.01% of outstanding | $87k | Oct 8, 2026 | none |
| Oct 8, 2025 | OCUL OCULAR THERAPEUTIX, INC. | 11,132 0.01% of outstanding | $137k | Oct 8, 2025 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Common Stock | +64,900 | $0.00 | $0 | 152,468 | Jan 6, 2026 |
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Stock Option (Right to Buy)derivative | +197,650 | $0.00 | $0 | 197,650 | Jan 6, 2026 |
| Oct 8, 2025 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -11,132 | $12.34 | $137k | 87,568 | Oct 10, 2025 |
Questions about Todd Anderman
Answered from the filings on this page, as of the latest one.
Is Todd Anderman buying or selling?
Not in the last 12 months. Todd Anderman's latest open-market trade on SEC Form 4 was sold $137k of OCUL on Oct 8, 2025.
How did Todd Anderman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Todd Anderman has 0.
Where does Todd Anderman file Form 4?
Todd Anderman has filed Form 4 at OCUL (OCULAR THERAPEUTIX, INC) as Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.